1Associate Professor, Dept. of Microbiology, Gian Sagar Medical College & Hospital, Punjab, India
2Assistant Professor, Dept. of Transfusion Medicine, Gian Sagar Medical College & Hospital, Punjab, India
3Assistant Professor, Dept. of Microbiology, Gian Sagar Medical College & Hospital, Punjab, India
4Professor & Head, Dept. of Microbiology, Gian Sagar Medical College & Hospital, Punjab, India
*Corresponding Author: E-mail: prernaaggarwal70@yahoo.com
Online published on 18 December, 2015.
To study the prevalence of HBsAg and HCV antibodies in patient population versus healthy blood donors (voluntary and replacement).
For both the parameter, rapid immunochromatographic kits were used followed by specific ELISA tests for patient population and ELISA screening in blood bank.
The HBsAg seropositivity was comparable in both groups and lower than the national prevalence. HCV antibodies seropositivity was significantly higher in patient population as compared to blood donors.
Inclusion of immunization against hepatitis B virus in the national program will help to curb its spread but for control of HCV, measures like micro screening of blood donors and checking drug addiction needs to be undertaken.
Hepatitis B surface antigen (HBsAg), Hepatitis C virus (HCV), Seropositivity, Prevalence
